EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 272 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,840,000 | -20.5% | 36,749 | 0.0% | 0.21% | -19.8% |
Q2 2021 | $2,315,000 | -32.2% | 36,749 | 0.0% | 0.26% | -33.9% |
Q1 2021 | $3,414,000 | +3.7% | 36,749 | 0.0% | 0.39% | -3.7% |
Q4 2020 | $3,293,000 | -13.3% | 36,749 | 0.0% | 0.40% | -27.5% |
Q3 2020 | $3,797,000 | +113.7% | 36,749 | +63.6% | 0.56% | +101.1% |
Q2 2020 | $1,777,000 | +36.7% | 22,467 | 0.0% | 0.28% | +12.6% |
Q1 2020 | $1,300,000 | +12900.0% | 22,467 | +10967.5% | 0.25% | +12200.0% |
Q1 2019 | $10,000 | -16.7% | 203 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $12,000 | -55.6% | 203 | -50.1% | 0.00% | -50.0% |
Q3 2018 | $27,000 | +28.6% | 407 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $21,000 | 0.0% | 407 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $21,000 | +10.5% | 407 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $19,000 | +18.8% | 407 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $16,000 | +14.3% | 407 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $14,000 | +16.7% | 407 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $12,000 | – | 407 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |